Background: Alzheimer's disease disproportionately affects women in the U.S., with two-thirds of individuals diagnosed being female. This gender disparity underscores the crucial role of sex as a significant risk factor for disease development. Recognizing the importance of this, it becomes imperative to investigate how Alzheimer's disease presents differently between males and females, especially in the early stages when intervention is most potent. The locus coeruleus (LC) is the initial brain region affected by hyper phosphorylated tau in Alzheimer's disease, preceding the accumulation of other pathological indicators. A deeper understanding of sex differences in this crucial region can provide insights into how Alzheimer's disease related dysfunction manifests uniquely between the sexes METHOD: In vivo electrophysiology under anesthesia was used to measure single unit activity of LC firing patterns in wild-type Fischer male and female rats. Females have been estrous cycle tracked and stratification between estrus phases may uncover further differences within females. Recordings measured tonic firing and phasic firing in response to footshock. Spike sorting and signal processing differentiated LC principal neurons and interneurons, unique units, physiological features, and bursting patterns that were compared between groups.
Result: This data shows no significant differences in LC principal cell tonic firing between males and females. However during burst firing, females have an increased interspike interval, indicating decreased firing supporting sexually distinct physiology of the LC. Additionally, females have distinct waveform patterns from males including area under the curve and peak/valley energies, suggesting possible differences in intrinsic properties.
Conclusion: Sex influences LC phasic physiology which may contribute to AD disproportionately impacting women.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/alz.085461 | DOI Listing |
Adv Sci (Weinh)
January 2025
School of Pharmacy, Sungkyunkwan University, Suwon, 16419, Republic of Korea.
β-secretase (BACE1) is instrumental in amyloid-β (Aβ) production, with overexpression noted in Alzheimer's disease (AD) neuropathology. The interaction of Aβ with the receptor for advanced glycation endproducts (RAGE) facilitates cerebral uptake of Aβ and exacerbates its neurotoxicity and neuroinflammation, further augmenting BACE1 expression. Given the limitations of previous BACE1 inhibition efforts, the study explores reducing BACE1 expression to mitigate AD pathology.
View Article and Find Full Text PDFActa Neuropathol Commun
January 2025
Department of Biological Sciences, Purdue University, 915 Mitch Daniels Blvd, West Lafayette, IN, USA.
Dementia refers to an umbrella phenotype of many different underlying pathologies with Alzheimer's disease (AD) being the most common type. Neuropathological examination remains the gold standard for accurate AD diagnosis, however, most that we know about AD genetics is based on Genome-Wide Association Studies (GWAS) of clinically defined AD. Such studies have identified multiple AD susceptibility variants with a significant portion of the heritability unexplained and highlighting the phenotypic and genetic heterogeneity of the clinically defined entity.
View Article and Find Full Text PDFNeurotherapeutics
January 2025
Department of Biochemistry, University of Alberta, Edmonton, Alberta, T6G 2H7, Canada. Electronic address:
Amyloidogenic protein aggregation is a pathological hallmark of Alzheimer's Disease (AD). As such, this critical feature of the disease has been instrumental in guiding research on the mechanistic basis of disease, diagnostic biomarkers and preventative and therapeutic treatments. Here we review identified molecular triggers and modulators of aggregation for two of the proteins associated with AD: amyloid beta and tau.
View Article and Find Full Text PDFInt J Biol Macromol
January 2025
First Operating Room, The First Hospital of Jilin University, Changchun, China. Electronic address:
Background: Certain peripheral proteins are believed to be involved in the development of Alzheimer's disease (AD), but the roles of other new protein biomarkers are still unclear. Current treatments aim to manage symptoms, but they are not effective in stopping the progression of the disease. New drug targets are needed to prevent Alzheimer's disease.
View Article and Find Full Text PDFNeuroscience
January 2025
Departamento de Genómica, Instituto de Investigaciones Biológicas Clemente Estable, MEC, Av. Italia 3318, Montevideo, CP 11600, Uruguay; Departamento de Biología Celular y Molecular, Facultad de Ciencias, Universidad de la República, Iguá, Montevideo, 4225, CP 11400, Uruguay. Electronic address:
Local protein synthesis (LPS) in axons is now recognized as a physiological process, participating both in the maintenance of axonal function and diverse plastic phenomena. In the last decades of the 20th century, the existence and function of axonal LPS were topics of significant debate. Very early, axonal LPS was thought not to occur at all and was later accepted to play roles only during development or in response to specific conditions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!